Michael DeBiasi's most recent trade in RVL Pharmaceuticals plc was a trade of 40,000 Ordinary Shares done . Disclosure was reported to the exchange on July 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc | Michael DeBiasi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 40,000 | 40,000 (0%) | 0% | 0 | Ordinary Shares |